In this essay, I argue that prescription drug laws violate patients' rights to self-medication. Patients have rights to self-medication for the same reasons they have rights to refuse medical treatment according to the doctrine of informed consent (DIC). Since we should accept the DIC, we ought to reject paternalistic prohibitions of prescription drugs and respect the right of self-medication. In section 1, I frame the puzzle of self-medication; why don't the same considerations that tell in favour of informed consent also justify a right of self-medication? In section 2, I show that the prescription drug system was historically motivated by paternalism. In section 3, I outline the justifications for the DIC in more detail. I show that consequentialist, epistemic, and deontic considerations justify the DIC. In sections 4–6, I argue that these considerations also justify rights of self-medication. I then propose that rights of self-medication require non-prohibitive prescription policies in section 7. I consider two objections in sections 8 and 9: that patients ought not to make medically risky or deadly decisions, and that unrestricted access to prescription-grade pharmaceuticals would result in widespread misuse and abuse. Section 10 concludes.
- Applied and Professional ethics
- right to refuse treatment
- political Philosophy
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Linked article Yes.
Competing interests None.
Provenance and peer review Commissioned; externally peer reviewed.
- The concise argument
Other content recommended for you
- The value of autonomy and the right to self-medication
- Advance decisions in dementia: when the past conflicts with the present
- Prescription requirements: a reply to Taylor, Martin and Eyal
- Reconciling informed consent with prescription drug requirements
- Highlights from this issue
- Cannabis, cannabis everywhere: UK to review medical cannabis policy as Canada plans imminent legalisation for all uses
- Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis
- Bioethics in a clinic for women with psychosis
- Refusal rights, law and medical paternalism in Turkey
- Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study